Download Sample, Rising Adoption of Endoscopic Procedures is Driving the Market Expansion
Increased usage of endoscopy includes diagnostics and treatment of diseases such as colorectal cancers, respiratory tract disorders, and digestive tract disorders. According to the National Centre for Biotechnology Information, approximately 15-20 million endoscopies are performed every year in the United States and about 2 million in France. Among endoscopes, colonoscopes and duodenoscopes are commonly used since there has been an incidence rate of colorectal cancer and GI diseases. Approximately 88.99 million DALYs were associated with digestive diseases worldwide in 2019. That is approximately 3.51 percent of total DALYs throughout the world. So gastroenterology is driving innovation along with new products, which are also coming into the scope of endoscopy.
Furthermore, around 1 in 1.8 million patients under procedure suffer from transmissions of infectious agents through the endoscope. Monitoring and location of diseases are essential functions of endoscopy, although sometimes it leaves the endoscopic instrument contaminated with microorganisms and other secretions from the body following each application.
According to the guidelines on reprocessing and infection control by the Healthcare Infection Control Practices Advisory Committee of Centres for Disease Control and Prevention, decontamination of an endoscope is necessary in order not to cross-contaminate other patients and avoid hospital-acquired infection. This is why a high level of disinfection from the FDA is required for endoscopes since they need quality assurance.
Furthermore, around 1 in 1.8 million patients under procedure suffer from transmissions of infectious agents through the endoscope. Monitoring and location of diseases are essential functions of endoscopy, although sometimes it leaves the endoscopic instrument contaminated with microorganisms and other secretions from the body following each application.
According to the guidelines on reprocessing and infection control by the Healthcare Infection Control Practices Advisory Committee of Centres for Disease Control and Prevention, decontamination of an endoscope is necessary in order not to cross-contaminate other patients and avoid hospital-acquired infection. This is why a high level of disinfection from the FDA is required for endoscopes since they need quality assurance.
Rise in Healthcare Expenditure and HAI Accelerate the Market Expansion
The potential of advanced medical devices and procedures is going to increase with the growing healthcare infrastructure across Asia-Pacific, Latin America, and Middle East regions. According to the reports, Asia Pacific now spends more than 9% in healthcare spending that is supposed to reach above 20% by 2030, and with modernizing the health systems through governmental and private sector investment, very rapid increases have occurred in the adoption of minimally invasive procedures due to endoscopic surgery through the last couple of years because these techniques are the most efficient in terms of benefits bestowed to the patient. This trend creates a high demand for automated endoscope reprocessing systems, ensuring safe and effective cleaning and disinfection of endoscopes, and meeting stringent hygiene standards.
Furthermore, an increased number of hospitalizations due to the rising incidence of different chronic diseases that contribute to enhancing HAI, also known as nosocomial infection. About 1 in 31 hospitalized patients suffer from nosocomial infection and the incidence rate accounts for 5% in North America and Europe as well as 40% in Asian, Latin American, and African countries. Consequently, healthcare authorities are focusing on the enhancement of reprocessing guidelines of endoscopic procedures to improve patient safety and lessen personal exposure to contamination.
Additionally, developments in enhanced processing techniques involving sterilization and high levels of disinfection led to the expansion of technologically advanced automated endoscope reprocessing. For instance, on 24 January 2024, Envirogen announced the launch of EndoTherm, a thermal sanitization range of healthcare water purifier for cleaning of reusable endoscopes to meet the new Association for the Advancement of Medical Instrumentation (AAMI) ST108 standard. Such factors propel the growth of the market.
Furthermore, an increased number of hospitalizations due to the rising incidence of different chronic diseases that contribute to enhancing HAI, also known as nosocomial infection. About 1 in 31 hospitalized patients suffer from nosocomial infection and the incidence rate accounts for 5% in North America and Europe as well as 40% in Asian, Latin American, and African countries. Consequently, healthcare authorities are focusing on the enhancement of reprocessing guidelines of endoscopic procedures to improve patient safety and lessen personal exposure to contamination.
Additionally, developments in enhanced processing techniques involving sterilization and high levels of disinfection led to the expansion of technologically advanced automated endoscope reprocessing. For instance, on 24 January 2024, Envirogen announced the launch of EndoTherm, a thermal sanitization range of healthcare water purifier for cleaning of reusable endoscopes to meet the new Association for the Advancement of Medical Instrumentation (AAMI) ST108 standard. Such factors propel the growth of the market.
Recent Trends in the Automated Endoscope Reprocessing Industry:
- Increased Adoption of Automated Systems for Infection Control
- Rising Demand for Eco-Friendly and Sustainable Reprocessing Solutions
- Integration of AI and Iot In Endoscope Reprocessing Systems
- Growing Awareness of Cross-Contamination Risks in Healthcare Settings
- Rising Healthcare Investments in Infection Prevention and Control Systems
Explore Our Breakthrough Market Segmentation and Personalize it to Meet Your Business Needs…!
High Cost, Operational Flaws and Alternative Products Present Threat for Automated Endoscope Reprocessing Market
The high cost of automated endoscope reprocessing systems is a significant barrier to market growth, especially for small healthcare facilities and clinics operating on limited budgets. These systems often require substantial capital investment, which can be challenging for smaller organizations to justify, particularly in low-resource settings.
Additionally, the cost of complementary accessories, consumables, and upgrades further adds to the financial burden. This price sensitivity is particularly evident in developing regions where manual cleaning methods are often preferred due to their affordability. The financial constraints faced by smaller healthcare providers limit the widespread adoption of these advanced systems, restraining market expansion.
Furthermore, complications associated with automated endoscope reprocessing instruments involve the possibility of transmission of infection ascribed to flaws in endoscopes and AERs as well as concerns related to accurate reprocessing owing to human errors, failure of sterilization equipment, incorrect selection of disinfectant and improper drying another limiting factor for the market. Additionally, endoscopic reprocessing suffers challenges such as hang time that leads to storage of endoscopes without reprocessing and issues in microbiological surveillance testing of endoscopes.
Emergence of substitute products for reusable endoscopes including single-use endoscopes and hybrid endoscopes containing disposable components that can be discarded after every use. Owing to challenges and difficulties during the cleaning and sterilization of reusable endoscopes aid to the adoption of alternative endoscopes. Recently, there is rise in the launch of hybrid and disposable endoscopes that hamper the growth of the automated endoscope reprocessing market.
For instance, on 18 September 2023, Olympus Corporation announced the release of Vathin E-SteriScope single-use flexible video rhinolaryngoscope for application of diagnostic and therapeutic procedures. Such factors hinder the growth of the market.
Additionally, the cost of complementary accessories, consumables, and upgrades further adds to the financial burden. This price sensitivity is particularly evident in developing regions where manual cleaning methods are often preferred due to their affordability. The financial constraints faced by smaller healthcare providers limit the widespread adoption of these advanced systems, restraining market expansion.
Furthermore, complications associated with automated endoscope reprocessing instruments involve the possibility of transmission of infection ascribed to flaws in endoscopes and AERs as well as concerns related to accurate reprocessing owing to human errors, failure of sterilization equipment, incorrect selection of disinfectant and improper drying another limiting factor for the market. Additionally, endoscopic reprocessing suffers challenges such as hang time that leads to storage of endoscopes without reprocessing and issues in microbiological surveillance testing of endoscopes.
Emergence of substitute products for reusable endoscopes including single-use endoscopes and hybrid endoscopes containing disposable components that can be discarded after every use. Owing to challenges and difficulties during the cleaning and sterilization of reusable endoscopes aid to the adoption of alternative endoscopes. Recently, there is rise in the launch of hybrid and disposable endoscopes that hamper the growth of the automated endoscope reprocessing market.
For instance, on 18 September 2023, Olympus Corporation announced the release of Vathin E-SteriScope single-use flexible video rhinolaryngoscope for application of diagnostic and therapeutic procedures. Such factors hinder the growth of the market.
New Product Innovations and Acquisitions by Key Players Propel the Market Growth
On November 22, 2023, HOYA Corporation completed the acquisition of WASSENBURG Medical B.V. by acquiring the remaining 49% of shares and therefore became the sole shareholder of the Dutch-based medical reprocessing company. The transaction is to further innovation in endoscope reprocessing solutions through combining the engineering know-how of WASSENBURG Medical with the flexible endoscopy division of PENTAX Medical.
Demand for automated endoscope reprocessing is due to the possibility of cross-contamination of endoscopes for the next round of endoscopic applications. That led to the development of new and innovative automated endoscope reprocessing instruments. For instance, Olympus released Olympus ETD in two versions, namely ETD Basic and ETD Premium, on June 13, 2023. These are new products of the Olympus Infection Prevention portfolio which aim to enhance the efficiency and sustainability of endoscope reprocessing and ensure improved cleaning and disinfection.
Additionally, PENTAX Medical U.S. introduced the PlasmaTYPHOONdry, an advanced endoscope drying solution to improve productivity and traceability, on 20 December 2022. The new system further optimizes the process of endoscope drying to better ensure patient safety; therefore, it reflects the company's commitment to innovation.
Demand for automated endoscope reprocessing is due to the possibility of cross-contamination of endoscopes for the next round of endoscopic applications. That led to the development of new and innovative automated endoscope reprocessing instruments. For instance, Olympus released Olympus ETD in two versions, namely ETD Basic and ETD Premium, on June 13, 2023. These are new products of the Olympus Infection Prevention portfolio which aim to enhance the efficiency and sustainability of endoscope reprocessing and ensure improved cleaning and disinfection.
Additionally, PENTAX Medical U.S. introduced the PlasmaTYPHOONdry, an advanced endoscope drying solution to improve productivity and traceability, on 20 December 2022. The new system further optimizes the process of endoscope drying to better ensure patient safety; therefore, it reflects the company's commitment to innovation.
Know Your Competitors and Strengthen Market Share Effectively
Rising Incidences of Digestive Diseases and Cancers Propels the Market Growth
North America is the leading regional market for automated endoscope reprocessing, mainly due to improved healthcare facilities and enhanced endoscopic procedures along with the growing incidence of digestive diseases and colorectal cancer, which compelled the healthcare professionals in this region to adopt GI endoscopy and colonoscopy, mainly in the U.S.
As reported by the American Society for Gastrointestinal Endoscopy (ASGE) in 'The Delivery of Gastrointestinal Endoscopy in the United States, approximately 60 to 70 million U.S. populations are suffering from digestive diseases, therefore gastroenterologists are treating patients of the most common, costly, and consequential diseases in America and the world.
Furthermore, it is estimated that approximately 106,590 new cases of colon cancer and approximately 46,220 new cases of rectal cancer with 53,010 expected deaths projected during 2024 in the United States. In addition, about 1 in 23 men and 1 in 25 women are at risk of developing colon cancer in their lifetime. These factors contribute to new product launches and strategic partnerships between major players. These factors propel market growth in this region.
Europe region accounts for another lucrative market owing to the rise in the prevalence of colorectal cancer in this region. Colorectal cancer ranks as the second most common cancer and the second cause of mortality in Europe. According to the European Cancer Information System, in 2022, there were estimated new cases of 361,986 colorectal cancers diagnosed in Europe, amounting to 13% of the total new cancer cases diagnosed in the region. Deaths attributed to colorectal cancer also totaled approximately 161,182, representing 12% of cancer-related deaths.
Furthermore, the market of automated endoscope reprocessing market is projected to grow the highest owing to the presence of large economies such as China and India. The rising demand for automated endoscope reprocessors is ascribed to collaboration and strategic developments among major market players. For instance, on July 10, 2023, HOYA Group and PENTAX Medical declared the establishment of an endoscope manufacturing, R&D, and services center in the Chinese market to speed up the delivery of endoscopic solutions from PENTAX Medical in China.
As reported by the American Society for Gastrointestinal Endoscopy (ASGE) in 'The Delivery of Gastrointestinal Endoscopy in the United States, approximately 60 to 70 million U.S. populations are suffering from digestive diseases, therefore gastroenterologists are treating patients of the most common, costly, and consequential diseases in America and the world.
Furthermore, it is estimated that approximately 106,590 new cases of colon cancer and approximately 46,220 new cases of rectal cancer with 53,010 expected deaths projected during 2024 in the United States. In addition, about 1 in 23 men and 1 in 25 women are at risk of developing colon cancer in their lifetime. These factors contribute to new product launches and strategic partnerships between major players. These factors propel market growth in this region.
Europe region accounts for another lucrative market owing to the rise in the prevalence of colorectal cancer in this region. Colorectal cancer ranks as the second most common cancer and the second cause of mortality in Europe. According to the European Cancer Information System, in 2022, there were estimated new cases of 361,986 colorectal cancers diagnosed in Europe, amounting to 13% of the total new cancer cases diagnosed in the region. Deaths attributed to colorectal cancer also totaled approximately 161,182, representing 12% of cancer-related deaths.
Furthermore, the market of automated endoscope reprocessing market is projected to grow the highest owing to the presence of large economies such as China and India. The rising demand for automated endoscope reprocessors is ascribed to collaboration and strategic developments among major market players. For instance, on July 10, 2023, HOYA Group and PENTAX Medical declared the establishment of an endoscope manufacturing, R&D, and services center in the Chinese market to speed up the delivery of endoscopic solutions from PENTAX Medical in China.
Searching for a Country or Region-Specific Report?
Unlock industry complexities with reports crafted for selected countries and regions at Reduced Cost
The report provides a detailed overview of the Automated endoscope reprocessing market insights in regions including North America, Latin America, Europe, Asia-Pacific, Oceania, and the Middle East and Africa. The country-specific assessment for Automated endoscope reprocessing market has been offered for all regional market share, along with forecasts, market scope estimates, price point assessment, and impact analysis of prominent countries and regions. Throughout this market research report, Y-o-Y growth and CAGR estimates are also incorporated for every country and region, to provide a detailed view of the Automated endoscope reprocessing market. These Y-o-Y projections on regional and country-level markets brighten the political, economic and business environment outlook, which are anticipated to have a substantial impact on the growth of the Automated endoscope reprocessing market. Some key country and region included in the Automated endoscope reprocessing market report as follows:
| Regions | Countries |
|---|---|
| North America | United States, Canada |
| Latin America | Brazil, Mexico, Argentina, Colombia, Chile, Rest of Latin America |
| Europe | Germany, United Kingdom, France, Italy, Spain, Russia, Netherlands, Switzerland, Belgium, Sweden, Austria, Norway, Denmark, Finland, Ireland, Czech Republic, Rest of Europe |
| Asia Pacific | China, India, Japan, South Korea, Australia & New Zealand, Singapore, Thailand, Malaysia, Indonesia, Philippines, Rest of Asia Pacific |
| Middle East and Africa | GCC Countries, South Africa, Egypt, Turkey, Morocco, Israel, Iran, Kenya, Nigeria, Rest of MEA |
Automated Endoscope Reprocessing Market Research Report Covers In-depth Analysis on:
- Automated endoscope reprocessing market detailed segments and segment-wise market breakdown
- Automated endoscope reprocessing market dynamics (Recent industry trends, drivers, restraints, growth potential, opportunities in automated endoscope reprocessing industry)
- Current, historical and forthcoming 10 years market valuation in terms of automated endoscope reprocessing market size (US$ Mn), share (%), Y-o-Y growth rate, CAGR (%) analysis
- Automated endoscope reprocessing market demand analysis
- Automated endoscope reprocessing market regional insights with region-wise market breakdown
- Competitive analysis – key companies profiling including their market share, product offerings, and competitive strategies.
- Latest developments and innovations in automated endoscope reprocessing market
- Regulatory landscape by key regions and key countries
- Automated endoscope reprocessing market sales and distribution strategies
- A comprehensive overview of parent market
- A detailed viewpoint on automated endoscope reprocessing market forecast by countries
- Mergers and acquisitions in automated endoscope reprocessing market
- Essential information to enhance market position
- Robust research methodology
- Frequently Asked Questions -
What are the primary market drivers influencing the automated endoscope reprocessing market?
The key market drivers include advancements in healthcare technology, increasing demand for infection control solutions, and stringent regulatory guidelines promoting safe and efficient reprocessing of medical equipment.
What are the emerging trends in the automated endoscope reprocessing market?
Emerging trends include the integration of artificial intelligence, automation advancements, environmentally sustainable reprocessing systems, and the development of user-friendly interfaces for healthcare providers.
What factors should manufacturers consider when entering the automated endoscope reprocessing market?
Manufacturers should focus on compliance with international safety standards, innovative product features, competitive pricing, and building strong partnerships with healthcare providers for market penetration.
